To detect CD8+ T cell responses we used in vitro transcribed (ivT) mRNA for antigen delivery, a method well-established in tumor immune therapy for the induction of cytotoxic T cell responses against cells presenting tumor antigens via MHCI [19–23]. This evidence concerns the gene CD8A and neoplasm.